BridgeBio Pharma, Inc. (BBIO) stock
BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$76.80−0.56 (-0.72%)
Close on Nov 17, 2026Market cap $14.96BP/E –Yield –
BridgeBio Pharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -16.1% | – |
| Q3 FY2025 | Sep 30, 2025 | -151.4% | – |
See a number that looks wrong?